EarningsQ4 2025 Earnings Report

Alnylam Pharma (DUL) Q4 2025 Earnings Report

0 Followers

CH:DUL Q4 2025 EPS Results

Actual EPSCHF0.68

Consensus EPSCHF0.95

Beat/MissMissed by -CHF0.27

One Year Ago EPS-CHF0.54

Actual RevenueCHF910.03M

Expected RevenueCHF953.23M

Beat/MissMissed by -CHF43.20M

YoY Revenue Growth+84.95%

QuarterQ4 2025

Date02/12/2026

TimeBefore Open

Conference CallThursday, February 12, 2026

CH:DUL Upcoming Earnings

Alnylam Pharma's next earnings date is estimated for October 29, 2026, based on past reporting schedules.

CH:DUL Q4 2025 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Oct 29, 2026	2026 (Q3)	1.45 / -	1.526	―
Jul 30, 2026	2026 (Q2)	1.35 / 1.00	-0.423	337.25% (+1.43)
Apr 30, 2026	2026 (Q1)	0.72 / 1.25	-0.365	443.18% (+1.62)
Feb 12, 2026	2025 (Q4)	0.95 / 0.68	-0.539	226.15% (+1.22)
Oct 30, 2025	2025 (Q3)	0.47 / 1.53	-0.722	311.49% (+2.25)
Jul 31, 2025	2025 (Q2)	-0.45 / -0.42	-0.108	-292.31% (-0.32)
May 01, 2025	2025 (Q1)	-0.74 / -0.36	-0.431	15.38% (+0.07)
Feb 13, 2025	2024 (Q4)	-0.49 / -0.54	-0.912	40.91% (+0.37)
Oct 31, 2024	2024 (Q3)	-0.76 / -0.72	0.954	-175.65% (-1.68)
Aug 01, 2024	2024 (Q2)	-0.89 / -0.11	-1.833	94.12% (+1.73)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed